Signal Genetics is a provider of diagnostic services that helps physicians make better-informed decisions for their patients suffering from cancer.
Business Model:
Revenue: $7.3M
Employees: 11-50
Signal Genetics, Inc was acquired by
Viridian Therapeutics.
The acquisition happend on 2016-11-02.
Details of the transaction were not public
Address: 6200 Lookout Road
City: Boulder
State: CO
Zip: 80301
Country: US
Signal Genetics is a provider of diagnostic services that helps physicians make better-informed decisions for their patients suffering from cancer.
Contact Phone:
+13035315952
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
6/27/2014
Ticker Symbol:
SGNL
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2010 | Seed Round | - |
BSL Capital Myeloma Institute for Research and Therapy UAMS BSL Capital Myeloma Institute for Research and Therapy UAMS |
1/2011 | Convertible Note | 1 | $25M |
BSL Capital BSL Capital |
6/2014 | IPO | $8.5M |
|
1/2010 | Seed Round | 2 | - |
BSL Capital Myeloma Institute for Research and Therapy UAMS BSL Capital Myeloma Institute for Research and Therapy UAMS |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|